United States Of America to India: Vaccine Import Trade Route
India has recorded 22 verified shipments of Vaccine imported from United States Of America, representing a combined trade value of $1.9M USD. This corridor is served by 1 active United States Of America exporters, with an average shipment value of $85.8K USD. The leading United States Of America supplier is XXETIXXBELXXUM XXA, which accounts for 100% of total import value with 22 shipments worth $1.9M USD. On the buying side, KERRY INDEV LOGISTICS PRIVATE LIMITED is the largest Indian importer with $1.9M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The United States Of America to India Vaccine corridor is one of India's established pharmaceutical import routes from United States Of America, with 22 shipments documented worth a combined $1.9M USD. The route is dominated by XXETIXXBELXXUM XXA, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of United States Of America's vaccine export sector.
Across 1 active United States Of America suppliers, the average shipment value stands at $85.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 12.7%, placing it at rank #4 among India's top vaccine import origins globally.
On the Indian buyer side, key Indian importers include KERRY INDEV LOGISTICS PRIVATE LIMITED. KERRY INDEV LOGISTICS PRIVATE LIMITED is the single largest Indian importer with 22 shipments valued at $1.9M USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top port of entryJ MATADEE CHENNAI FTZ
Market Position
- Global rank#4
- Annual growth+12.7%
- Demand growth+13.0%
- Regulatory ease68/100
Top 10 Vaccine Exporters from United States Of America to India
Showing top 10 of 1 United States Of America suppliers exporting Vaccine to India, ranked by total trade value (USD)
| Rank | Supplier (United States Of America Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XXETIXXBELXXUM XXA Avg $85.8K per shipment | 22 | $1.9M | 100.0% |
This table shows the top 10 of 1 United States Of America companies exporting vaccine to India, ranked by total trade value. The listed exporters are: XXETIXXBELXXUM XXA. XXETIXXBELXXUM XXA is the dominant supplier with 22 shipments worth $1.9M USD, giving it a 100% market share.
Top 10 Indian Vaccine Importers from United States Of America
Showing top 10 of 1 known Indian buyers receiving Vaccine shipments from United States Of America, ranked by import value
On the receiving end of this trade route, the leading Indian importers of United States Of America vaccine include KERRY INDEV LOGISTICS PRIVATE LIMITED. The largest importer is KERRY INDEV LOGISTICS PRIVATE LIMITED, accounting for $1.9M USD across 22 shipments — representing 100% of all vaccine imports from United States Of America on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KERRY INDEV LOGISTICS PRIVATE LIMITED | 22 | $1.9M | 100.0% |
Top 10 Vaccine Formulations Imported from United States Of America
Showing top 10 of 19 product formulations shipped on the United States Of America to India Vaccine route, ranked by trade value
India imports a wide range of vaccine formulations from United States Of America, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MAREKS DISEASE- NEWCASTLE DISEASE VACCINE SEROTYPE 3 LIVE MAREKS DISEASE VECTOR(POULVAC PROCERTA HVT-ND) 2000 DS(BATCH — accounts for $389.9K USD across 2 shipments. There are 19 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MAREKS DISEASE- NEWCASTLE DISEASE VACCINE SEROTYPE 3 LIVE MAREKS DISEASE VECTOR(POULVAC PROCERTA HVT-ND) 2000 DS(BATCH | 2 | $389.9K | 20.6% |
| 2 | FELINE RHINOTRACHEITIS-CALICI-PANLEUKOPENIA-VACCINE MODIFIED LIVE VIRUS (FELOCELL 3) (BATCH NO : 710623)(SERIAL NO: 68 | 1 | $286.9K | 15.2% |
| 3 | BURSAL DISEASE VACCINE LIVE VIRUS (BURSAPLEX 10 X 2000 DS) BATCH NO : 686592 | 1 | $282.1K | 14.9% |
| 4 | REO VIRUS VACCINE INACTIVATED IP (TRI - REO VAC 1000 DS)BATCH NO : 676207 | 1 | $168.6K | 8.9% |
| 5 | FELINE RHINOTRACHEITIS-CALICI-PANLEUKOPENIA-VACCINE MODIFIED LIVE VIRUS (FELOCELL 3)(BATCH NO : 692916)(SERIAL NO: 6625 (INV) | 1 | $163.6K | 8.7% |
| 6 | MAREK'S DISEASE VACCINE LIVE IP(VVMD VAC 1000 DS)BATCH NO : 692541 | 1 | $133.3K | 7.1% |
| 7 | MAREKS DISEASE- NEWCASTLE DISEASE VACCINE SEROTYPE 3 LIVE MAREKS DISEASE VECTOR (POULVAC PROCERTA HVT-ND) 2000 DS(BATC | 2 | $120.6K | 6.4% |
| 8 | MAREK'S DISEASE VACCINE LIVE IP (VVMD VAC 1000DS)(BATCH NO : 676686) | 1 | $110.4K | 5.8% |
| 9 | MAREK'S DISEASE VACCINE LIVE IP (VVMD VAC 1000 DS)BATCH NO : 692541 | 2 | $99.1K | 5.2% |
| 10 | REO VIRUS VACCINE INACTIVATED IP (TRI - REO VAC 1000 DS)BATCH NO : 676208 | 1 | $90.4K | 4.8% |
Showing top 10 of 19 Vaccine formulations imported from United States Of America on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Indian Ports of Entry
J MATADEE CHENNAI FTZ handles the highest volume with 17 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's vaccine imports from United States Of America are driven primarily by a handful of large-scale United States Of America manufacturers. XXETIXXBELXXUM XXA with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States Of America supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — XXETIXXBELXXUM XXA — together account for 100% of total trade value on this route. The average shipment value of $85.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as feline rhinotracheitis-calici-panleukopenia-vaccine modified live virus (felocell 3) (batch no : 710623)(serial no: 68 and bursal disease vaccine live virus (bursaplex 10 x 2000 ds) batch no : 686592, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States Of America supplier.
On the buying side, KERRY INDEV LOGISTICS PRIVATE LIMITED is the largest importer with 22 shipments worth $1.9M USD — representing 100% of all vaccine imports from United States Of America on this route.
Route Statistics
- Trade Volume
- $1.9M
- Avg. Shipment
- $85.8K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~16 days
- Annual Growth
- +12.7%
Other Vaccine Routes
Unlock the Full United States Of America to India Vaccine Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 22 shipments on this route.
Frequently Asked Questions — United States Of America to India Vaccine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which United States Of America companies export Vaccine to India?
The leading United States Of America exporters of Vaccine to India are XXETIXXBELXXUM XXA. XXETIXXBELXXUM XXA holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Vaccine imports from United States Of America to India?
India imports Vaccine from United States Of America worth approximately $1.9M USD across 22 recorded shipments. The average value per shipment is $85.8K USD.
Q Which Indian ports receive Vaccine from United States Of America?
The most active Indian port of entry is J MATADEE CHENNAI FTZ with 17 shipments. United States Of America exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from United States Of America to India for Vaccine?
The average transit time for Vaccine shipments from United States Of America to India is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the United States Of America to India Vaccine import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.7% with demand growth tracking at 13.0%. The route is ranked #4 among India's top Vaccine import origins globally.
Q How many United States Of America suppliers are active on this Vaccine import route?
There are currently 1 active United States Of America suppliers exporting Vaccine to India. The market is moderately concentrated with XXETIXXBELXXUM XXA accounting for 100% of total shipment value.
Q Who are the main Indian importers of Vaccine from United States Of America?
The leading Indian importers of Vaccine from United States Of America include KERRY INDEV LOGISTICS PRIVATE LIMITED. KERRY INDEV LOGISTICS PRIVATE LIMITED is the largest buyer with 22 shipments worth $1.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States Of America export trade corridor identified from Indian Customs (DGFT) records for Vaccine.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in United States Of America matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 22 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
22 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists